1-183945493-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_015101.4(COLGALT2):c.1208C>T(p.Ser403Phe) variant causes a missense change. The variant allele was found at a frequency of 0.000535 in 1,614,208 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00041 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00055 ( 2 hom. )
Consequence
COLGALT2
NM_015101.4 missense
NM_015101.4 missense
Scores
13
6
Clinical Significance
Conservation
PhyloP100: 5.67
Genes affected
COLGALT2 (HGNC:16790): (collagen beta(1-O)galactosyltransferase 2) Predicted to enable procollagen galactosyltransferase activity. Predicted to be involved in collagen fibril organization. Predicted to be located in endoplasmic reticulum lumen. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.24344319).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COLGALT2 | NM_015101.4 | c.1208C>T | p.Ser403Phe | missense_variant | 9/12 | ENST00000361927.9 | NP_055916.1 | |
COLGALT2 | NM_001303420.2 | c.1208C>T | p.Ser403Phe | missense_variant | 9/12 | NP_001290349.1 | ||
COLGALT2 | NM_001303421.2 | c.848C>T | p.Ser283Phe | missense_variant | 9/12 | NP_001290350.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COLGALT2 | ENST00000361927.9 | c.1208C>T | p.Ser403Phe | missense_variant | 9/12 | 1 | NM_015101.4 | ENSP00000354960.4 | ||
COLGALT2 | ENST00000649786.1 | c.1208C>T | p.Ser403Phe | missense_variant | 9/12 | ENSP00000497601.1 | ||||
COLGALT2 | ENST00000367520.3 | c.419C>T | p.Ser140Phe | missense_variant | 4/7 | 2 | ENSP00000356490.3 | |||
COLGALT2 | ENST00000367521.5 | c.32C>T | p.Ser11Phe | missense_variant | 1/4 | 2 | ENSP00000356491.1 |
Frequencies
GnomAD3 genomes AF: 0.000407 AC: 62AN: 152208Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
62
AN:
152208
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000489 AC: 123AN: 251390Hom.: 0 AF XY: 0.000523 AC XY: 71AN XY: 135850
GnomAD3 exomes
AF:
AC:
123
AN:
251390
Hom.:
AF XY:
AC XY:
71
AN XY:
135850
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000549 AC: 802AN: 1461882Hom.: 2 Cov.: 31 AF XY: 0.000531 AC XY: 386AN XY: 727246
GnomAD4 exome
AF:
AC:
802
AN:
1461882
Hom.:
Cov.:
31
AF XY:
AC XY:
386
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000407 AC: 62AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74484
GnomAD4 genome
AF:
AC:
62
AN:
152326
Hom.:
Cov.:
32
AF XY:
AC XY:
19
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
5
ALSPAC
AF:
AC:
3
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
59
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.1208C>T (p.S403F) alteration is located in exon 9 (coding exon 9) of the COLGALT2 gene. This alteration results from a C to T substitution at nucleotide position 1208, causing the serine (S) at amino acid position 403 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;.;M;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;D;D;D
REVEL
Uncertain
Sift
Uncertain
.;D;D;D
Sift4G
Uncertain
.;D;D;D
Polyphen
0.97, 0.98
.;.;D;D
Vest4
0.37, 0.42, 0.43
MVP
0.88
MPC
0.96
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at